Management of Focal Nodular Hyperplasia (FNH)
Conservative management is recommended for patients with focal nodular hyperplasia (FNH), with surgery reserved only for specific cases with symptoms or rapid growth. 1, 2
Characteristics and Epidemiology
- FNH is the second most common benign liver tumor after hemangioma, with a prevalence of 0.3% to 3% in the general population 1
- It occurs predominantly in reproductive-aged women, with a female-to-male ratio estimated at 26:1 1
- FNH is characterized by focal hyperplasia within normal liver tissue and may be influenced by steroid hormones, though the relationship with estrogen exposure remains controversial 3
Diagnostic Approach
- Diagnosis can be established through non-invasive imaging techniques:
- Contrast-enhanced ultrasound (CEUS) typically shows strong hyperperfusion from a large feeding artery in the arterial phase, creating a characteristic spoke-wheel appearance 3
- MRI with liver-specific contrast agents provides high diagnostic accuracy, especially for lesions larger than 3.5 cm 4
- Typical findings include a central scar and homogeneous enhancement pattern 4
- Liver biopsy should be avoided as it is not necessary for diagnosis and carries a risk of bleeding 3
Management Recommendations
- Conservative management is the standard approach for asymptomatic FNH 2, 1
- Surgical intervention is indicated only in specific circumstances:
- Unlike hepatic adenomas, FNH has an extremely low risk of spontaneous rupture, with only rare cases reported in the literature 1, 7
Special Considerations for Pregnancy
- Pregnancy is not contraindicated in women with FNH 3, 1
- Vaginal delivery is not associated with increased risks 3, 1
- Routine imaging surveillance is not recommended during pregnancy 3
- In a study of 20 pregnant women with FNH, size remained constant or decreased in most patients, with no FNH-related complications 3
Potential Pitfalls
- FNH may be mistaken for hepatocellular carcinoma on imaging, particularly when the liver appears nodular 3
- FNH can coexist with other vascular hepatic lesions such as hemangiomas in up to 20% of cases 1
- Unlike hepatic adenomas, which require close monitoring during pregnancy, FNH does not require special surveillance 1
- Focal nodular hyperplasia is frequently found in patients with hereditary hemorrhagic telangiectasia (HHT), with a prevalence 100-fold greater than in the general population 3
Follow-up Recommendations
- Long-term follow-up studies show that conservative management is effective in over 94% of cases 2
- Initially asymptomatic patients typically remain symptom-free during follow-up 2
- Periodic imaging may be considered for larger lesions, but there is no strong evidence supporting routine surveillance 1, 2